COOTNA ▲ 0%
BHPNA▼ 0%
CBANA ▲ 0%
CSLNA ▲ 0%
NABNA ▼ 0%
WBCNA ▲ 0%
COOTNA ▲ 0%
BHPNA▼ 0%
CBANA ▲ 0%
CSLNA ▲ 0%
NABNA ▼ 0%
WBCNA ▲ 0%
Filing Date
Form
Description
Filing Group
View
July 14, 2025
2025
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )
July 1, 2025
2025
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )
June 23, 2025
2025
This prospectus is part of a registration statement on Form S-1 that we filed with the Securities and Exchange Commission (the “SEC”) whereby the Selling Securityholders may, from time to time, sell the Ordinary Shares described in this prospectus. We will not receive any proceeds from the sale by the Selling Shareholders of the Ordinary Shares described in this prospectus, however we may receive proceeds from the sale of Ordinary Shares to Arena pursuant to the Purchase Agreement. See also “Use of Proceeds” in this prospectus.
June 18, 2025
2025
This prospectus is part of a registration statement on Form S-1 that we filed with the Securities and Exchange Commission (the “SEC”) whereby the Selling Securityholders may, from time to time, sell the Ordinary Shares described in this prospectus. We will not receive any proceeds from the sale by the Selling Shareholders of the Ordinary Shares described in this prospectus, however we may receive proceeds from the sale of Ordinary Shares to Arena pursuant to the Purchase Agreement. See also “Use of Proceeds” in this prospectus.
June 10, 2025
2025
This prospectus is part of a registration statement on Form S-1 that we filed with the Securities and Exchange Commission (the “SEC”) whereby the Selling Securityholders may, from time to time, sell the Ordinary Shares described in this prospectus. We will not receive any proceeds from the sale by the Selling Shareholders of the Ordinary Shares described in this prospectus, however we may receive proceeds from the sale of Ordinary Shares to Arena pursuant to the Purchase Agreement. See also “Use of Proceeds” in this prospectus.
June 4, 2025
2025
current report pursuant to section 13 or 15(d) of the securities exchange act of 1934
Annual Fillings
May 30, 2025
2025
Quarterly report which provides a continuing view of the company for Q3 2025, detailing financial position, operational achievements, and strategic outlook for the upcoming period.
Quarterly Fillings
May 22, 2025
2025
current report pursuant to section 13 or 15(d) of the securities exchange act of 1934
Annual Fillings
May 14, 2025
2025
This prospectus is part of a registration statement on Form S-1 that we filed with the Securities and Exchange Commission (the “SEC”) whereby the Selling Securityholders may, from time to time, sell the Ordinary Shares described in this prospectus. We will not receive any proceeds from the sale by the Selling Shareholders of the Ordinary Shares described in this prospectus, however we may receive proceeds from the sale of Ordinary Shares to Arena pursuant to the Purchase Agreement. See also “Use of Proceeds” in this prospectus.
